[go: up one dir, main page]

0% found this document useful (0 votes)
12 views6 pages

القائمة السادسةمستورد لقرار 450 لسنة 2023

The document lists approved medications by the Egyptian Drug Authority as of December 26, 2024, under the third condition of Ministerial Decision No. 450 for the year 2023. These medications will be effective from January 2025 until the end of March 2025 and include both local and imported products. The list contains various generic names, concentrations, and dosage forms of the medications.

Uploaded by

Mohamed Mohamady
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
12 views6 pages

القائمة السادسةمستورد لقرار 450 لسنة 2023

The document lists approved medications by the Egyptian Drug Authority as of December 26, 2024, under the third condition of Ministerial Decision No. 450 for the year 2023. These medications will be effective from January 2025 until the end of March 2025 and include both local and imported products. The list contains various generic names, concentrations, and dosage forms of the medications.

Uploaded by

Mohamed Mohamady
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 6

‫‪Arab Republic of Egypt‬‬ ‫ﺟﻣﮭورﯾﺔ ﻣﺻر اﻟﻌرﺑﯾﺔ‬

‫‪Egyptian Drug Authority‬‬ ‫ھﯾﺋﺔ اﻟدواء اﻟﻣﺻرﯾﺔ‬

‫ﻗﺎﺋﻤﺔ اﻟﻤﺴﺘﺤﻀﺮات اﻟﻤﻌﺘﻤﺪة ﻣﻦ اﻟﻠﺠﻨﺔ اﻟﻔﻨﯿﺔ ﻟﻤﺮاﻗﺒﺔ اﻷدوﯾﺔ‬


‫ﺑﺠﻠﺴﺘﮭﺎ ﻓﻲ ‪٢٠٢٤/١٢/٢٦‬‬

‫وﻓﻘﺎ ً ﻟﻠﺤﺎﻟﺔ اﻟﺜﺎﻟﺜﺔ ﻣﻦ اﻟﻘﺮار اﻟﻮزاري رﻗﻢ )‪ (٤٥٠‬ﻟﺴﻨﺔ ‪٢٠٢٣‬‬

‫)ﺳﺎري اﻟﻌﻤﻞ ﺑﮭﺎ ﻣﻨﺬ ﯾﻨﺎﯾﺮ ‪ ٢٠٢٥‬وﺣﺘﻰ ﻧﮭﺎﯾﺔ ﻣﺎرس ‪(٢٠٢٥‬‬


‫وذﻟﻚ ﻟﻠﻤﺴﺘﺤﻀﺮات )ﻣﺤﻠﻲ‪-‬ﻣﺴﺘﻮرد(‬

‫)اﻟﻘﺎﺋﻤﺔ اﻟﺴﺎدﺳﺔ(‬
Arab Republic of Egypt ‫ﺟﻣﮭورﯾﺔ ﻣﺻر اﻟﻌرﺑﯾﺔ‬
Egyptian Drug Authority ‫ھﯾﺋﺔ اﻟدواء اﻟﻣﺻرﯾﺔ‬

� ‫ض‬ ‫ض‬
‫ﻠﻤﺴﺘﺤ�ات اﻟﻤﻌﺘﻤﺪة ت‬
‫كﻤﺴﺘﺤ�ات ﻣﺴﺘﻮردة وﻓﻘﺎ ﻟﻠﺤﺎﻟﺔ‬ ‫اﻟى �ﺴﻤﺢ بﺎﻟﺘﻘﺪم ﻋﻠﻴﻬﺎ‬ ‫اﻟﻘﺎﺋﻤﺔ اﻟﺴﺎدﺳﺔ ﻟ‬
٢٠٢٣ ‫ ﻟﺴﻨﺔ‬٤٥٠ ‫اﻟﺜﺎﻟﺜﺔ ﻣﻦ اﻟﻘﺮار اﻟﻮزاري رﻗﻢ‬

‫ﻃبﻘﺎ ش‬ ‫)ﺳﺎري اﻟﻌﻤﻞ ﺑﻬﺎ ت‬
(‫ﻟﻠ�وط اﻟﻤﻌﻠﻨﺔ‬ ٢٠٢٥ ‫ﺣى ﻧﻬﺎ�ﺔ ﻣﺎرس‬
NO. Generic Name Conc. Dosage Form
1 ACYCLOVIR 3% EYE OINT.
2 Adenosine 3mg/ml Injection
3 AMANTADINE SULPHATE 200 mg/500ml Injection
4 Anidulafungin 100 mg Injection
5 Aztreonam 1G Injection
Prolonged
6 BUPROPION HYDROCHLORIDE 150 mg
release tablets
7 Busulphan 2 mg Tablet
CALCIUM GLUCONATE + CALCIUM
8 0.5 gm+ 0.342 gm/10ml Injection
LEVULINATE
9 Carfilzomib 60mg Injection
10 CARBIMAZOLE 5 mg Tablet
50 mg Injection
11 caspofungin
70 mg Injection
12 CLARITHROMYCIN 500mg Injection
13 Cetrorelix 0.25mg Injection
14 CLONAZEPAM 2.5 mg/ml Oral Drops
15 Colistimethate Sodium 1 M IU Injection
ALL EYE DROPS
50mg/ml Injection
16 CYCLOSPORIN
250mg/5ml Injection
100 mg/ml Oral Solution
17 DEXMEDETOMIDINE 100 mcg/ml Injection
0.5mg/2ml Injection
18 DIGOXIN
0.05Mg/ML Syrup
Prolonged
19 DOXAZOSIN 4mg
release tablets
Ethyl Esters of the Iodized Fatty Acids of
20 480 mg/ml Injection
Poppy Seed Oil
21 Erlotinib 150mg Tablet
22 Exemestane 25 mg Tablet
Transdermal
100MCG/HR
Patch
Transdermal
12MCG/HR
Patch
Transdermal
23 FENTANYL 25MCG/HR
Patch
Transdermal
50MCG/HR
Patch
Transdermal
75mcg/HR
Patch
24 Fingolimod 0.5mg Capsule
25 FLUMAZENIL 0.5mg/5ml Injection
26 FLUORESCEIN SODIUM 500mg/5ml Injection
27 GANCICLOVIR 500MG Injection
٥ ‫ ﻣن‬۱ ‫ﺻﻔـ ـﺤ ـﺔ‬
Arab Republic of Egypt ‫ﺟﻣﮭورﯾﺔ ﻣﺻر اﻟﻌرﺑﯾﺔ‬
Egyptian Drug Authority ‫ھﯾﺋﺔ اﻟدواء اﻟﻣﺻرﯾﺔ‬

� ‫ض‬ ‫ض‬
‫ﻠﻤﺴﺘﺤ�ات اﻟﻤﻌﺘﻤﺪة ت‬
‫كﻤﺴﺘﺤ�ات ﻣﺴﺘﻮردة وﻓﻘﺎ ﻟﻠﺤﺎﻟﺔ‬ ‫اﻟى �ﺴﻤﺢ بﺎﻟﺘﻘﺪم ﻋﻠﻴﻬﺎ‬ ‫اﻟﻘﺎﺋﻤﺔ اﻟﺴﺎدﺳﺔ ﻟ‬
٢٠٢٣ ‫ ﻟﺴﻨﺔ‬٤٥٠ ‫اﻟﺜﺎﻟﺜﺔ ﻣﻦ اﻟﻘﺮار اﻟﻮزاري رﻗﻢ‬

‫ﻃبﻘﺎ ش‬ ‫)ﺳﺎري اﻟﻌﻤﻞ ﺑﻬﺎ ت‬
(‫ﻟﻠ�وط اﻟﻤﻌﻠﻨﺔ‬ ٢٠٢٥ ‫ﺣى ﻧﻬﺎ�ﺔ ﻣﺎرس‬
NO. Generic Name Conc. Dosage Form
28 GLYCERYL TRINITRATE 1mg/ml Injection
1% EYE OINT.
29 HYDROCORTISONE Acetate
2.5% EYE OINT.
30 Hydroxyurea 500 mg Capsule
31 Ibrutinib 140mg Capsule
Prolonged
32 ISOSORBIDE MONONITRATE 60mg
release tablets
33 Lapatinib 250 mg Tablet
100mcg Injection
34 Levothyroxin 200mcg Injection
500mcg Injection
100mg/25mg Tablet
35 Lopinavir/ritonavir
200mg/50mg Tablet
10 mg/ml Injection
36 MORPHINE
20 mg/ml Injection
37 MICAFUNGIN 50 MG Injection
18MG X.R. Tablet
38 METHYL PHENIDATE
36MG X.R. Tablet
39 Milrinone 1mg/ ml Injection
500 mg Injection
40 Methyl prednisolone
1G Injection
41 Methyl ergometrine maleate 0.2mg/ml Injection
Gastro Resistant
180 mg
Tablet
42 Mycophenolate sodium
Gastro Resistant
360 mg
Tablet
43 Naloxone 0.4mg/ml Injection
44 Nimodipine 0.02% Injection
45 NORTRIPTYLINE +FLUPHENAZINE 10mg + 0.5mg Tablet
46 NORETHISTERONE +ESTRADIOL VALERATE 50MG +5MG/ML Injection
47 NORGESTREL +ESTRADIOL VALERATE 0.5mg + 2mg Tablet
48 obidoxime chloride 250mg/ml Injection
49 Octreotide 30 mg Injection
50mg/ml Injection
50 Pethidine
100mg/ 2 ml Injection
51 PENICILLAMINE 250MG Capsule
52 PROPRANOLOL 1mg/ml Injection
75mg Capsule
53 Palbociclib 100mg Capsule
125mg Capsule
200mg Tablet
54 Pazopanib
400mg Tablet
55 PROPAMIDINE ISETIONATE 1 mg/ml EYE DROPS
56 PHENOBARBITONE + METHYL 50mg +50mg+50mg Tablet

٥ ‫ ﻣن‬۲ ‫ﺻﻔـ ـﺤ ـﺔ‬


Arab Republic of Egypt ‫ﺟﻣﮭورﯾﺔ ﻣﺻر اﻟﻌرﺑﯾﺔ‬
Egyptian Drug Authority ‫ھﯾﺋﺔ اﻟدواء اﻟﻣﺻرﯾﺔ‬

� ‫ض‬ ‫ض‬
‫ﻠﻤﺴﺘﺤ�ات اﻟﻤﻌﺘﻤﺪة ت‬
‫كﻤﺴﺘﺤ�ات ﻣﺴﺘﻮردة وﻓﻘﺎ ﻟﻠﺤﺎﻟﺔ‬ ‫اﻟى �ﺴﻤﺢ بﺎﻟﺘﻘﺪم ﻋﻠﻴﻬﺎ‬ ‫اﻟﻘﺎﺋﻤﺔ اﻟﺴﺎدﺳﺔ ﻟ‬
٢٠٢٣ ‫ ﻟﺴﻨﺔ‬٤٥٠ ‫اﻟﺜﺎﻟﺜﺔ ﻣﻦ اﻟﻘﺮار اﻟﻮزاري رﻗﻢ‬

‫ﻃبﻘﺎ ش‬ ‫)ﺳﺎري اﻟﻌﻤﻞ ﺑﻬﺎ ت‬
(‫ﻟﻠ�وط اﻟﻤﻌﻠﻨﺔ‬ ٢٠٢٥ ‫ﺣى ﻧﻬﺎ�ﺔ ﻣﺎرس‬
NO. Generic Name Conc. Dosage Form
PHENOBARBITONE + Diphenylhydantoin
57 Regorafenib 40mg Tablet
58 Riluzole 50mg Tablet
5mg Tablet
Ruxolitinib
59 15mg Tablet
60 Sorafenib 200 mg Tablet
61 Sirolimus 1 mg Tablet
62 Suxamethonium Chloride 100mg/5ml Injection
63 Teriflunomide 14mg Tablet
64 TOBRAMYCIN 80MG/2ML Injection
65 Triptorelin acetate 3.75 mg Prefilled Syringe
66 TIGECYCLINE 50 mg Injection
100 mg/2ml Injection
67 ZUCLOPENTHIXOL
200 mg/ml Injection
Film Coated
100 mg +25 mg + 200 mg
Tablets
Film Coated
50 mg +12.5 mg + 200 mg
Tablets
68 LEVODOPA+CARBIDOPA+ENTACAPONE
Film Coated
200 mg +50 mg + 200 mg
Tablets
Film Coated
150 mg +40.5 mg + 200 mg
Tablets
69 Succimer (DMSA) 100 mg Capsule
70 Edaravone 30 mg / 100 ml Injection
71 VIGABATRIN 500 mg Film Tab
72 Amphotericin B encapsulated in liposomes 50,000 units Injection
73 Amphotericin B 50 mg Injection
74 Nimodipine 30 mg Tab
75 Arsenic Trioxide 1mg/mL Injection
76 Pentamidine 300 mg Injection
77 doxorubicin liposomal 2mg/mL Injection
78 Sodium nitroprusside 50 mg/2ml Injection
79 Dutasteride + Tamsulosin 0.5mg + 0.4mg MR Capsule
80 Valganciclovir 450 mg Tab
100mg Tab
81 Abemaciclib 150 mg Tab
200 mg Tab
82 Abiraterone Acetate 500 mg Tab
83 Alectinib 150 mg capsule
84 Bortezomib 3.5 mg Vial
85 Olaparib 150 mg Tab
86 Ribociclib 200 mg Tab
87 Svelamer 800 mg Tab
88 Ceftazidime+Avibactam 2/.5 gm Vial

٥ ‫ ﻣن‬۳ ‫ﺻﻔـ ـﺤ ـﺔ‬


Arab Republic of Egypt ‫ﺟﻣﮭورﯾﺔ ﻣﺻر اﻟﻌرﺑﯾﺔ‬
Egyptian Drug Authority ‫ھﯾﺋﺔ اﻟدواء اﻟﻣﺻرﯾﺔ‬

� ‫ض‬ ‫ض‬
‫ﻠﻤﺴﺘﺤ�ات اﻟﻤﻌﺘﻤﺪة ت‬
‫كﻤﺴﺘﺤ�ات ﻣﺴﺘﻮردة وﻓﻘﺎ ﻟﻠﺤﺎﻟﺔ‬ ‫اﻟى �ﺴﻤﺢ بﺎﻟﺘﻘﺪم ﻋﻠﻴﻬﺎ‬ ‫اﻟﻘﺎﺋﻤﺔ اﻟﺴﺎدﺳﺔ ﻟ‬
٢٠٢٣ ‫ ﻟﺴﻨﺔ‬٤٥٠ ‫اﻟﺜﺎﻟﺜﺔ ﻣﻦ اﻟﻘﺮار اﻟﻮزاري رﻗﻢ‬

‫ﻃبﻘﺎ ش‬ ‫)ﺳﺎري اﻟﻌﻤﻞ ﺑﻬﺎ ت‬
(‫ﻟﻠ�وط اﻟﻤﻌﻠﻨﺔ‬ ٢٠٢٥ ‫ﺣى ﻧﻬﺎ�ﺔ ﻣﺎرس‬
NO. Generic Name Conc. Dosage Form
89 Nitisinone 10mg Tablet
80 mg
90 Degralix Vial
120 mg
Rivastigmine 9 MG Patch
91
18 MG
Dl-Alpha IV INFUSION
92
Tocopherol+Ergocalciferol+Retinol+Vitamink1
93 L-Alanyl-L-Glutamine IV INFUSION
SODIUM FLUORIDE 210 Mcg/Ml ; POTASSIUM IV INFUSION
IODIDE 16.6 Mcg/Ml ; Sodium Molybdate
Dihydrate 4.85 Mcg/Ml ; Manganese (II)-
Chloride-Tetrahydrate 19.79 Mcg/Ml ; Zinc
94 Chloride 1050 Mcg/Ml ; Cupric Chloride
Dihydrate 102.3 Mcg/Ml ; Chromic Chloride
Hexahydrate 5.33 Mcg/Ml ; Ferric (Iron III)
Chloride Hexahydrate 540 Mcg/Ml ; Sodium
Selenite Anhydrous 17.29 Mcg/Ml ;
GLUCOSE 130 mg/ml, Soybean Oil 60
mg/ml, TRIGLYCERIDE 60 mg/ml,
OLIVE OIL 50mg/ml, FISH OIL30
mg/ml, ALANINE 14 mg/ml,
SODIUM ACETATE 3.400 mg/ml ; ARGININE 12 mg/ml, Proline 11.2
METHIONINE 4.300 mg/ml ; ARGININE 12.000 mg/ml, THREONINE 4.4 mg/ml,
mg/ml ; POTASSIUM CHLORIDE ANHYDROUS METHIONINE 4.3 mg/ml,
4.480 mg/ml ; ALANINE 14.000 mg/ml ; POTASSIUM CHLORIDE
GLYCINE 11.000 mg/ml ; CALCIUM CHLORIDE ANHYDROUS4.48 mg/ml, GLYCINE 11
0.560 mg/ml ; ZINC SULPHATE 12.900 mcg/ml mg/ml, Sodium Glyerophosphate
95 ; OLIVE OIL 50.000 mg/ml ; GLUCOSE 130.000 anhydrous 4.18 mg/ml, LYSINE 6.6 IV INFUSION
mg/ml ; LYSINE 6.600 mg/ml ; MAGNESIUM mg/ml, HISTIDINE 3 mg/ml,
SULPHATE 1.200 mg/ml ; FISH OIL 30.000 MAGNESIUM SULPHATE 1.2 mg/ml,
mg/ml ; TRIGLYCERIDE 60.000 mg/ml ; TRYPTOPHAN 2 mg/ml, L-SERINE
ISOLEUCINE 5.000 mg/ml ; L-SERINE 6.500 6.5mg/ml, L-VALINE 6.2mg/ml, l-
mg/ml ; THREONINE 4.400 mg/ml ; Soybean taurine 1mg, SODIUM ACETATE
Oil 60.000 mg/ml ; TRYPTOPHAN 2.000 m 3.4mg/ml, CALCIUM CHLORIDE
0.56mg/ml, PHENYLALANINE
5.1mg/ml, Tyrosine0.4mg/ml, l-
leucine7.4 mg/ml, ISOLEUCINE 5
mg/ml, ZINC SULPHATE 12.9mcg/ml
Gadolinium oxide 90.62 mg + Tetraxetan 279.3 mg Amp.
96
202.46 mg
Solution for
97 Eribulin Mesylate 1.13 mg/2ml Intravenous
Injection
98 Osimertinib 80mg 80 mg Tablet
99 Enzalutamide 40mg 40mg Capsules
100 Venetoclax 100mg 100 mg Tablet

٥ ‫ ﻣن‬٤ ‫ﺻﻔـ ـﺤ ـﺔ‬


‫‪Arab Republic of Egypt‬‬ ‫ﺟﻣﮭورﯾﺔ ﻣﺻر اﻟﻌرﺑﯾﺔ‬
‫‪Egyptian Drug Authority‬‬ ‫ھﯾﺋﺔ اﻟدواء اﻟﻣﺻرﯾﺔ‬

‫�‬ ‫ض‬ ‫ض‬


‫ﻠﻤﺴﺘﺤ�ات اﻟﻤﻌﺘﻤﺪة ت‬
‫كﻤﺴﺘﺤ�ات ﻣﺴﺘﻮردة وﻓﻘﺎ ﻟﻠﺤﺎﻟﺔ‬ ‫اﻟى �ﺴﻤﺢ بﺎﻟﺘﻘﺪم ﻋﻠﻴﻬﺎ‬ ‫اﻟﻘﺎﺋﻤﺔ اﻟﺴﺎدﺳﺔ ﻟ‬
‫اﻟﺜﺎﻟﺜﺔ ﻣﻦ اﻟﻘﺮار اﻟﻮزاري رﻗﻢ ‪ ٤٥٠‬ﻟﺴﻨﺔ ‪٢٠٢٣‬‬
‫�‬
‫ﻃبﻘﺎ ش‬ ‫)ﺳﺎري اﻟﻌﻤﻞ ﺑﻬﺎ ت‬
‫ﻟﻠ�وط اﻟﻤﻌﻠﻨﺔ(‬ ‫ﺣى ﻧﻬﺎ�ﺔ ﻣﺎرس ‪٢٠٢٥‬‬
‫‪NO.‬‬ ‫‪Generic Name‬‬ ‫‪Conc.‬‬ ‫‪Dosage Form‬‬
‫‪101 Apalutamide 60mg‬‬ ‫‪60mg‬‬ ‫‪Tablet‬‬
‫‪25mg‬‬
‫‪102 lorlatinib‬‬ ‫‪Tablet‬‬
‫‪100mg‬‬
‫‪103 Tofacitinib 5mg‬‬ ‫‪5mg‬‬ ‫‪Capsules‬‬

‫ﺻﻔـ ـﺤ ـﺔ ‪ ٥‬ﻣن ‪٥‬‬

You might also like